Summit Therapeutics Inc [SMMT] Revenue clocked in at $0.00 million, up 80.08% YTD: What’s Next?
Summit Therapeutics Inc [NASDAQ: SMMT] price surged by 19.59 percent to reach at $0.77. The one-year SMMT stock forecast points to a potential upside of 41.25. The average equity rating for SMMT stock is currently 1.00, trading closer to a bullish pattern in the stock